PMC:7076992 / 86-549 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":21,"end":29},"obj":"Disease"},{"id":"T4","span":{"begin":161,"end":170},"obj":"Disease"},{"id":"T5","span":{"begin":359,"end":367},"obj":"Disease"},{"id":"T6","span":{"begin":370,"end":379},"obj":"Disease"},{"id":"T7","span":{"begin":423,"end":458},"obj":"Disease"},{"id":"T8","span":{"begin":429,"end":458},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"}],"text":"Coronavirus disease (COVID-19), which appeared in December 2019, presents a global challenge, particularly in the rapid increase of critically ill patients with pneumonia and absence of definitive treatment. To date, over 81,000 cases have been confirmed, with over 2700 deaths. The mortality appears to be around 2%; early published data indicate 25.9% with SARS-CoV-2 pneumonia required ICU admission and 20.1% developed acute respiratory distress syndrome [1]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":74,"end":75},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Coronavirus disease (COVID-19), which appeared in December 2019, presents a global challenge, particularly in the rapid increase of critically ill patients with pneumonia and absence of definitive treatment. To date, over 81,000 cases have been confirmed, with over 2700 deaths. The mortality appears to be around 2%; early published data indicate 25.9% with SARS-CoV-2 pneumonia required ICU admission and 20.1% developed acute respiratory distress syndrome [1]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":161,"end":170},"obj":"Phenotype"},{"id":"T2","span":{"begin":370,"end":379},"obj":"Phenotype"},{"id":"T3","span":{"begin":429,"end":449},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"Coronavirus disease (COVID-19), which appeared in December 2019, presents a global challenge, particularly in the rapid increase of critically ill patients with pneumonia and absence of definitive treatment. To date, over 81,000 cases have been confirmed, with over 2700 deaths. The mortality appears to be around 2%; early published data indicate 25.9% with SARS-CoV-2 pneumonia required ICU admission and 20.1% developed acute respiratory distress syndrome [1]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":207},"obj":"Sentence"},{"id":"T4","span":{"begin":208,"end":278},"obj":"Sentence"},{"id":"T5","span":{"begin":279,"end":463},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Coronavirus disease (COVID-19), which appeared in December 2019, presents a global challenge, particularly in the rapid increase of critically ill patients with pneumonia and absence of definitive treatment. To date, over 81,000 cases have been confirmed, with over 2700 deaths. The mortality appears to be around 2%; early published data indicate 25.9% with SARS-CoV-2 pneumonia required ICU admission and 20.1% developed acute respiratory distress syndrome [1]."}

{"project":"2_test","denotations":[{"id":"32178711-32081636-23646622","span":{"begin":460,"end":461},"obj":"32081636"}],"text":"Coronavirus disease (COVID-19), which appeared in December 2019, presents a global challenge, particularly in the rapid increase of critically ill patients with pneumonia and absence of definitive treatment. To date, over 81,000 cases have been confirmed, with over 2700 deaths. The mortality appears to be around 2%; early published data indicate 25.9% with SARS-CoV-2 pneumonia required ICU admission and 20.1% developed acute respiratory distress syndrome [1]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"13","span":{"begin":147,"end":155},"obj":"Species"},{"id":"14","span":{"begin":0,"end":19},"obj":"Disease"},{"id":"15","span":{"begin":21,"end":29},"obj":"Disease"},{"id":"16","span":{"begin":132,"end":146},"obj":"Disease"},{"id":"17","span":{"begin":161,"end":170},"obj":"Disease"},{"id":"18","span":{"begin":271,"end":277},"obj":"Disease"},{"id":"19","span":{"begin":283,"end":292},"obj":"Disease"},{"id":"20","span":{"begin":359,"end":379},"obj":"Disease"},{"id":"21","span":{"begin":423,"end":458},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"tao:has_database_id","subj":"13","obj":"Tax:9606"},{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"MESH:D018352"},{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"MESH:C000657245"},{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"MESH:D016638"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:D011014"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"MESH:D003643"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D003643"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:C000657245"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Coronavirus disease (COVID-19), which appeared in December 2019, presents a global challenge, particularly in the rapid increase of critically ill patients with pneumonia and absence of definitive treatment. To date, over 81,000 cases have been confirmed, with over 2700 deaths. The mortality appears to be around 2%; early published data indicate 25.9% with SARS-CoV-2 pneumonia required ICU admission and 20.1% developed acute respiratory distress syndrome [1]."}